ANAPTYSBIO, INC. Form CORRESP: Company correspondence with SEC staff
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-11-13: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2022-01-07: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2018-09-19: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
- 2017-10-10: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-11-13 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2022-01-07 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2018-09-19 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-10-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-10-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-10-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-01-23 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-01-23 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2017-01-10 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2016-12-28 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2016-03-22 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2016-01-11 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2015-09-24 | CORRESP | Company correspondence with SEC staff | filename1.htm | |
| 2015-09-09 | CORRESP | Company correspondence with SEC staff | filename1.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |